These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 7936382)
1. [Therapeutic protocols compared in the treatment of postmenopausal osteoporotic disease]. Nardo F; Scrofani V; Costa G; Bellanca S; Petrovec MM; Clemenza F; Licciardello S Minerva Ginecol; 1994 Jun; 46(6):305-15. PubMed ID: 7936382 [TBL] [Abstract][Full Text] [Related]
2. [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate]. Buffo L; Rossini M; Buoncristiano A; Girardello S; Zamberlan N; Diani F; Adami S Minerva Ginecol; 1996 Jun; 48(6):263-72. PubMed ID: 8927288 [TBL] [Abstract][Full Text] [Related]
3. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women. Arrenbrecht S; Caubel P; Garnero P; Felsenberg D Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience. Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620 [TBL] [Abstract][Full Text] [Related]
5. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women. Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654 [TBL] [Abstract][Full Text] [Related]
6. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial. Bunyavejchevin S; Limpaphayom KK J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499 [TBL] [Abstract][Full Text] [Related]
7. New possibilities for diagnosis and treatment of osteoporosis. Miller PD Int J Fertil Womens Med; 2001; 46(4):215-21. PubMed ID: 11563832 [TBL] [Abstract][Full Text] [Related]
8. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes]. Brodowska A Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843 [TBL] [Abstract][Full Text] [Related]
9. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover]. Celi M; Balducci S; Schiappoli A; Caliumi C; Petramala L; Cerci S; Cotesta D; D'Erasmo E; Letizia C Ann Ital Med Int; 2003; 18(2):89-98. PubMed ID: 12886826 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss]. Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868 [TBL] [Abstract][Full Text] [Related]
12. [The effect of different "coherent"-type therapeutic plans on bone mineral density and on the incidence of vertebral fractures in advanced osteoporosis]. Cristallini S; Pedetti M; Donatelli C; Gregorio F; Filipponi P Recenti Prog Med; 1993 May; 84(5):336-45. PubMed ID: 8390084 [TBL] [Abstract][Full Text] [Related]
13. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)]. Rosa J; Vanuga P; Payer J; Svobodník A Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288 [TBL] [Abstract][Full Text] [Related]
14. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history. La Vignera S; Vicari E; Tumino S; Ciotta L; Condorelli R; Vicari LO; Calogero AE Minerva Ginecol; 2008 Dec; 60(6):475-84. PubMed ID: 18981975 [TBL] [Abstract][Full Text] [Related]
15. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524 [TBL] [Abstract][Full Text] [Related]
17. [Effects of warm needle moxibustion on bone mass density and biochemical indexes of bone metabolism in patients of postmenopausal osteoporosis]. Zhao LH; Nong ZN; Zhong X; Pang Y; Liang JS; Li XD; Ye FW Zhongguo Zhen Jiu; 2008 Dec; 28(12):897-900. PubMed ID: 19127918 [TBL] [Abstract][Full Text] [Related]
18. The different routes of administration and the effect of hormone replacement therapy on osteoporosis. Christiansen C Fertil Steril; 1994 Dec; 62(6 Suppl 2):152S-156S. PubMed ID: 7958010 [TBL] [Abstract][Full Text] [Related]
19. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192 [TBL] [Abstract][Full Text] [Related]
20. Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis. Ruan XY; Jin FY; Liu YL; Peng ZL; Sun YG Chin Med J (Engl); 2008 Jul; 121(13):1155-8. PubMed ID: 18710630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]